Navigation Links
Isolation Sciences Takes Their Patented CAP Isolation Technology Nationally and Worldwide

Williamsville, NY (PRWEB) November 26, 2013

Isolation Sciences is proud to announce that they are taking their patented Continuous Access Port (CAP) technology nationally and worldwide.

This technology aims to improve the energy efficiency of ventilated laboratory fume hoods and improve the containment capability of laboratory safety enclosures. National resellers, such as Siemens, Pharmaceutical Containment Technologies, and Newmatic Engineering Inc, and worldwide resellers, such as Jon Dec Engineering Ltd (Western Australia) and Airex (Japan), are introducing the CAP technology into new markets.

“We do not make fume hoods; we make them more energy efficient and improve containment capability in fume hood operations,” said Isolation Sciences CEO, Charles Akers.

Fume Hood CAP is a retrofit to any existing laboratory fume hood which improves the energy efficiency of the fume hood by lowering the amount of heated/cooled facility air that must be exhausted to the outdoors, resulting in greater than 80 percent reduction of energy costs in fume hood operations. It also improves the containment capability of an enclosure by restricting the ability of contaminates to leave the fume hood and entering the laboratory environment, resulting in cleaner breathing air in the laboratory space.

Siemens Building Technology, Isolation Sciences’ launch partner, has been focused on making existing laboratory fume hoods energy efficient in laboratories with an ROI of less than six months. The Fume Hood CAP is an integral part of Siemens’ Green Laboratory Solution to make research buildings into more energy efficient facilities.

Isolation Sciences is now expanding its network of resellers with distribution channels such as Newmatic Engineering, Inc (NEI) in southern and northern California and Pharmaceutical Containment Technologies in St. Louis, MO.

NEI modifies laboratory and fume hood air handling controls to improve energy efficiency in research/development and manufacturing facilities in southern and northern California. PCT is a custom fabricator of containment enclosures for the pharmaceutical and chemical industry. They are incorporating Isolation Sciences patented technology into laboratory enclosures to improve on the accessibility to work within an enclosure while still maintaining the desired containment required for safe operation.

Isolation Sciences has entered the international market in pharma containment enclosure with two companies that are integrating their CAP technology into pharmaceutical research and development laboratories: JohnDec Engineering Pty Ltd in Australia and Airex in Japan.

JohnDec fabricates custom designed pharmaceutical enclosures for laboratory use in the Australian and New Zealand markets. Airex is a fabricator of pharmaceutical containment enclosures (Isolators) and reseller of the Fume Hood CAP for pharmaceutical laboratory fume hoods for the Japan market.

For more information about Isolation Sciences and their new CAP technology, visit their website at

<br>About the Company:<br>Isolation Sciences LLC is an innovation leader in providing value added, practical energy management products to realize savings in commercial laboratory energy consumption and isolation/containment risk management solutions to protect individuals against airborne chemical and biological vapors and aerosols that are hazardous to human health. The company’s patented Continuous Access Port [CAP] concept provides practical and cost efficient air containment solutions to meet energy and risk management needs in the commercial, academic and medical markets. For more information, visit Isolation Sciences’ website at

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. MO BIO Laboratories, Inc. Launches the PowerMicrobiome™ RNA Isolation Kit
2. MO BIO Laboratories, Inc. launches two new kits for high-throughput DNA isolation from plants and seeds
3. Garage Start-ups Now Possible in Life Sciences Industry
4. Ambit Biosciences Names Michael A. Martino President and Chief Executive Officer
5. DiaTech Life Sciences Announces Medical Advisory Board
6. The Law Firm of Levi & Korsinsky, LLP Launches an Investigation Into Possible Securities Laws Violations by Pacific Biosciences of California, Inc.
7. Coronado Biosciences to Present at the Oppenheimer 22nd Annual Healthcare Conference
8. Coronado Biosciences Announces Phase 1 Results of CNDO-109 in AML to be Presented at the American Society of Hematology
9. Sangamo BioSciences Announces Presentation of New Data from ZFP Therapeutic® Program in Hemophilia B at American Society for Hematology Meeting
10. At-the-Market Offerings (ATM) of Life Sciences Companies Perform Well in Weak Follow-on Financing Environment of Third Quarter
11. Sangamo BioSciences Announces Presentation at J.P. Morgan Healthcare Conference
Post Your Comments:
(Date:10/10/2017)... ... October 10, 2017 , ... ... company advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that ... Polymerized Liposomal Nanoparticle), a technology developed in collaboration with Children’s Hospital Los ...
(Date:10/10/2017)... SANTA CRUZ, Calif. , Oct. 10, 2017 /PRNewswire/ ... SBIR grant from the NIH to develop RealSeq®-SC (Single ... preparation kit for profiling small RNAs (including microRNAs) from ... Cell Analysis Program highlights the need to accelerate development ... "New techniques for ...
(Date:10/9/2017)... , ... October 09, 2017 , ... The award-winning American ... broadcast first quarter 2018. American Farmer airs Tuesdays at 8:30aET on RFD-TV. , ... faced with the challenge of how to continue to feed a growing nation. At ...
(Date:10/7/2017)... Phoenix, Arizona (PRWEB) , ... ... ... than 15 years’ experience providing advanced instruments and applications consulting for microscopy ... the in-house expertise in application consulting, Nanoscience Analytical offers a broad range ...
Breaking Biology Technology:
(Date:4/5/2017)... YORK , April 5, 2017 Today ... is announcing that the server component of the HYPR ... known for providing the end-to-end security architecture that empowers ... HYPR has already secured over 15 million ... makers including manufacturers of connected home product suites and ...
(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
(Date:3/30/2017)... Trends, opportunities and forecast in this market ... (fingerprint, AFIS, iris recognition, facial recognition, hand geometry, vein ... use industry (government and law enforcement, commercial and retail, ... others), and by region ( North America ... Pacific , and the Rest of the World) ...
Breaking Biology News(10 mins):